Table 1. Demographic and clinical data of the patient cohorts profiled for expression of RAGE proteins and polymorphisms.

Demographic and Clinical Data	Mean ± SD (N = 340)
BMI	48.1±9.08
Age (yrs)	44±11.3
Non-NASH NAFLD	42.1% (143)
NASH	30.3% (103)
Normal liver histology/No liver disease	27.6% (93)
Pericellular liver fibrosis	29.1% (99)
ALT (U/L)	34.59±25.92
AST (U/L)	26.37±19.35
Glucose (mg/dL)	108.88±36.76
Triglycerides (mg/dL)	157.9±93.4
Total cholesterol (mg/dL)	187.6±39.3

BMI: Body Mass Index; AGE: Advanced Glycation End Products; esRAGE: Endogenous Receptor for Advanced Glycation Products; sRAGE: Soluble Receptor for Advanced Glycation; AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase; HDL: High Density Lipoproteins